• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么肥胖男性感染 SARS-CoV-2 更为严重?肠道淋巴管-肺轴假说。

Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis.

机构信息

Department of Gastroenterology, IBD and Nutritional Support, CHU Paris Nord-Val de Seine, Beaujon Hospital, Clichy, France.

Department of Gastroenterology, IBD and Nutritional Support, CHU Paris Nord-Val de Seine, Beaujon Hospital, Clichy, France.

出版信息

Med Hypotheses. 2020 Nov;144:110023. doi: 10.1016/j.mehy.2020.110023. Epub 2020 Jun 23.

DOI:10.1016/j.mehy.2020.110023
PMID:32593832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7308746/
Abstract

Consistent observations report increased severity of SARS-CoV-2 infection in overweight men with cardiovascular factors. As the visceral fat possesses an intense immune activity, is involved in metabolic syndrome and is at the crossroad between the intestines, the systemic circulation and the lung, we hypothesized that it plays a major role in severe forms of SARS-CoV-2 infection. SARS-CoV2 presents the ability to infect epithelial cells of the respiratory tract as well as the intestinal tract. Several factors may increase intestinal permeability including direct enterocyte damage by SARS-CoV2, systemic inflammatory response syndrome (SIRS) and epithelial ischemia secondary to SARS-CoV2- associated endothelial dysfunction. This increase permeability further leads to translocation of microbial components such as MAMPs (microbial-associated molecular pattern), triggering an inflammatory immune response by TLR-expressing cells of the mesentery fat (mostly macrophages and adipocytes). The pro-inflammatory cytokines produced by the mesentery fat mediates systemic inflammation and aggravate acute respiratory distress syndrome (ARDS) through the mesenteric lymph drainage.

摘要

一致的观察报告表明,超重且伴有心血管因素的男性感染 SARS-CoV-2 的严重程度更高。由于内脏脂肪具有强烈的免疫活性,与代谢综合征有关,并处于肠道、全身循环和肺部之间的交叉点,我们假设它在 SARS-CoV-2 感染的严重形式中起主要作用。SARS-CoV2 具有感染呼吸道和肠道上皮细胞的能力。多种因素可能会增加肠道通透性,包括 SARS-CoV2 对肠细胞的直接损伤、全身性炎症反应综合征(SIRS)和 SARS-CoV2 相关内皮功能障碍导致的上皮缺血。这种通透性的增加进一步导致微生物成分(如 MAMPs)的易位,触发肠系膜脂肪中 TLR 表达细胞(主要是巨噬细胞和脂肪细胞)的炎症免疫反应。肠系膜脂肪产生的促炎细胞因子通过肠系膜淋巴引流介导全身炎症,并通过肠内淋巴引流加重急性呼吸窘迫综合征(ARDS)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09a/7308746/0dfc4176282e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09a/7308746/0dfc4176282e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09a/7308746/0dfc4176282e/gr1_lrg.jpg

相似文献

1
Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis.为什么肥胖男性感染 SARS-CoV-2 更为严重?肠道淋巴管-肺轴假说。
Med Hypotheses. 2020 Nov;144:110023. doi: 10.1016/j.mehy.2020.110023. Epub 2020 Jun 23.
2
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.肠道通透性的改变伴随着细菌易位,是调节机体对 SARS-CoV-2 全身免疫反应的关键事件:一个工作假说。
Dig Liver Dis. 2020 Dec;52(12):1383-1389. doi: 10.1016/j.dld.2020.09.009. Epub 2020 Sep 16.
3
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.概述:由 SARS-CoV-2 感染引起的肺损伤导致的全身炎症反应解释了 COVID-19 的严重结局。
Front Immunol. 2020 Jun 26;11:1626. doi: 10.3389/fimmu.2020.01626. eCollection 2020.
4
Adipose tissue extrinsic factor: Obesity-induced inflammation and the role of the visceral lymph node.脂肪组织外在因素:肥胖诱导的炎症及内脏淋巴结的作用
Physiol Behav. 2018 Jun 1;190:71-81. doi: 10.1016/j.physbeh.2018.02.044. Epub 2018 Mar 1.
5
Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.SARS-CoV-2 感染者血浆细胞因子水平升高不会导致肺微血管内皮通透性增加。
Microbiol Spectr. 2022 Feb 23;10(1):e0167121. doi: 10.1128/spectrum.01671-21. Epub 2022 Feb 16.
6
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.新型冠状病毒-19(SARS-CoV-2)通过白细胞介素-1(IL-1)引起细胞因子风暴导致 COVID-19 的急性重症肺部炎症:一种有前途的抑制策略。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E.
7
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.严重 COVID-19 中失调的干扰素反应和免疫过度激活:靶向 STATs 作为一种新的治疗策略。
Front Immunol. 2022 May 17;13:888897. doi: 10.3389/fimmu.2022.888897. eCollection 2022.
8
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.色氨酸代谢物和芳烃受体在严重急性呼吸综合征、冠状病毒-2 (SARS-CoV-2) 发病机制中的作用。
Int J Mol Sci. 2021 Feb 5;22(4):1597. doi: 10.3390/ijms22041597.
9
Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.感染 SARS-CoV-2 后肠道微生物组的改变与仓鼠疾病严重程度相关。
Gut Microbes. 2022 Jan-Dec;14(1):2018900. doi: 10.1080/19490976.2021.2018900.
10
Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters.肠道微生物组的组成和代谢产物的改变与肥胖 NASH 仓鼠的 COVID-19 样严重程度相关。
Gut Microbes. 2022 Jan-Dec;14(1):2100200. doi: 10.1080/19490976.2022.2100200.

引用本文的文献

1
COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.COVID-19 影响肠道菌群失调、急性后期后遗症、免疫调节和治疗方案。
Front Cell Infect Microbiol. 2024 May 28;14:1384939. doi: 10.3389/fcimb.2024.1384939. eCollection 2024.
2
Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study.肠道微生物组对 COVID-19 易感性和严重程度的因果影响:两样本孟德尔随机化研究。
Front Immunol. 2023 Sep 1;14:1173974. doi: 10.3389/fimmu.2023.1173974. eCollection 2023.
3
Nursing diagnoses in hospitalized patients with COVID-19 in Indonesia.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
3
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
印度尼西亚新冠肺炎住院患者的护理诊断
Belitung Nurs J. 2022 Feb 22;8(1):44-52. doi: 10.33546/bnj.1828. eCollection 2022.
4
A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.从综合角度看肠道微生物群与 COVID-19 疫苗的相互作用。
Gut Microbes. 2023 Jan-Dec;15(1):2233146. doi: 10.1080/19490976.2023.2233146.
5
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.肠道微生物群与 COVID-19 进展的关系:对免疫发病机制和治疗的新认识。
Front Immunol. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336. eCollection 2023.
6
Gut distress and intervention communications of SARS-CoV-2 with mucosal exposome.肠道不适与干预 SARS-CoV-2 与黏膜暴露组学的交流。
Front Public Health. 2023 Apr 17;11:1098774. doi: 10.3389/fpubh.2023.1098774. eCollection 2023.
7
Diarrhea Is a Hallmark of Inflammation in Pediatric COVID-19.腹泻是儿科 COVID-19 炎症的标志。
Viruses. 2022 Dec 6;14(12):2723. doi: 10.3390/v14122723.
8
Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients.紧密连接蛋白(zonulin)是肠道通透性的标志物,与秘鲁 COVID-19 住院患者队列的死亡率相关。
Front Cell Infect Microbiol. 2022 Sep 6;12:1000291. doi: 10.3389/fcimb.2022.1000291. eCollection 2022.
9
Excess Body Mass-A Factor Leading to the Deterioration of COVID-19 and Its Complications-A Narrative Review.超重是导致 COVID-19 及其并发症恶化的因素——一项叙述性综述。
Viruses. 2021 Dec 3;13(12):2427. doi: 10.3390/v13122427.
10
Mediterranean Diet a Potential Strategy against SARS-CoV-2 Infection: A Narrative Review.地中海饮食可能是对抗 SARS-CoV-2 感染的一种策略:叙述性综述。
Medicina (Kaunas). 2021 Dec 20;57(12):1389. doi: 10.3390/medicina57121389.
III 型干扰素在控制 SARS-CoV-2 感染人肠上皮细胞中的关键作用。
Cell Rep. 2020 Jul 7;32(1):107863. doi: 10.1016/j.celrep.2020.107863. Epub 2020 Jun 19.
4
Real-time tracking of self-reported symptoms to predict potential COVID-19.实时跟踪自我报告的症状以预测潜在的 COVID-19。
Nat Med. 2020 Jul;26(7):1037-1040. doi: 10.1038/s41591-020-0916-2. Epub 2020 May 11.
5
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.托珠单抗治疗可降低 COVID-19 患者的重症监护病房入院率和/或死亡率。
Med Mal Infect. 2020 Aug;50(5):397-400. doi: 10.1016/j.medmal.2020.05.001. Epub 2020 May 6.
6
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症:单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
7
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.托珠单抗治疗伴有炎症过度反应和急性呼吸衰竭的重症 COVID-19 肺炎:意大利布雷西亚单中心 100 例患者研究。
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
8
SARS-CoV-2 productively infects human gut enterocytes.SARS-CoV-2 能有效地感染人类肠道肠细胞。
Science. 2020 Jul 3;369(6499):50-54. doi: 10.1126/science.abc1669. Epub 2020 May 1.
9
Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.是时候考虑肺损伤的组织学模式来治疗新冠肺炎感染的重症患者了。
Intensive Care Med. 2020 Jun;46(6):1124-1126. doi: 10.1007/s00134-020-06057-8. Epub 2020 Apr 23.
10
Faecal calprotectin indicates intestinal inflammation in COVID-19.粪便钙卫蛋白提示新冠病毒感染患者存在肠道炎症。
Gut. 2020 Aug;69(8):1543-1544. doi: 10.1136/gutjnl-2020-321388. Epub 2020 Apr 20.